Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by high disease burden in some countries, as well as delays in reaching mortality targets due to the long natural history of disease progression to liver cirrhosis and hepatocellular carcinoma.
A peer-based needle exchange service in London
Download
Funded by Hackney Council as part of the ADDER (addiction, diversion, disruption, enforcement and recovery) Accelerator project, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) have a released a report exploring the feasibility, acceptability, and practical considerations of developing a peer-based needle exchange service. It draws on focus groups with people who use needle exchange services and peer support workers, interviews with experts from services and commissioning bodies, and international evidence.
